Page last updated: 2024-11-05

thiotepa and Carcinoid Tumor

thiotepa has been researched along with Carcinoid Tumor in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Carcinoid Tumor: A usually small, slow-growing neoplasm composed of islands of rounded, oxyphilic, or spindle-shaped cells of medium size, with moderately small vesicular nuclei, and covered by intact mucosa with a yellow cut surface. The tumor can occur anywhere in the gastrointestinal tract (and in the lungs and other sites); approximately 90% arise in the appendix. It is now established that these tumors are of neuroendocrine origin and derive from a primitive stem cell. (From Stedman, 25th ed & Holland et al., Cancer Medicine, 3d ed, p1182)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ley, R1
Vanderhoeft, P1

Other Studies

1 other study available for thiotepa and Carcinoid Tumor

ArticleYear
[Bronchial carcinoid. Apropos of 5 cases, one of which was a carcinoid syndrome].
    Acta chirurgica Belgica, 1969, Volume: 68, Issue:4

    Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Bronchial Neoplasms; Carcinoid Tumor; Carcinoma, Adenoi

1969
chemdatabank.com